Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Alan Murakami, M.D.

Concepts (142)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Mantle-Cell120232400.720 Why?
Lymphoma, B-Cell120239450.550 Why?
Bone Marrow1202429350.440 Why?
Guanylate Cyclase120232060.210 Why?
CARD Signaling Adaptor Proteins120231650.200 Why?
Xenograft Model Antitumor Assays4201836110.190 Why?
Asparaginase120222400.190 Why?
Tissue and Organ Harvesting120243730.180 Why?
Leukemia, B-Cell12020860.170 Why?
Proto-Oncogene Proteins c-mdm2220183620.160 Why?
Leukocyte Elastase220111140.150 Why?
Lymphoma, Extranodal NK-T-Cell12018530.150 Why?
Micro-Electrical-Mechanical Systems12016300.140 Why?
Bone Marrow Cells1202424140.130 Why?
Bone Marrow Transplantation1202427090.130 Why?
Lymphoma, T-Cell120183080.130 Why?
src-Family Kinases120185390.120 Why?
Tissue Banks120161830.120 Why?
Receptors, Antigen, B-Cell120185470.120 Why?
Drug Screening Assays, Antitumor120167190.110 Why?
Neoplasms32017223710.110 Why?
Cell Transformation, Neoplastic2202028460.110 Why?
Neoplasm, Residual1201810150.100 Why?
Antibodies, Monoclonal, Murine-Derived120156960.100 Why?
Lab-On-A-Chip Devices120164450.100 Why?
Neoplasms, Experimental1201612300.090 Why?
Agranulocytosis12011980.090 Why?
Lymphoma, Follicular120154600.090 Why?
Lymphoma, Non-Hodgkin1201813750.090 Why?
Escherichia coli1202242140.090 Why?
Hematologic Neoplasms1202119070.080 Why?
Hematopoietic Stem Cells1202134090.080 Why?
Granulocytes120115510.080 Why?
Unfolded Protein Response120112390.080 Why?
Granulocyte Precursor Cells12007490.070 Why?
Leukemia1201615190.070 Why?
Tumor Suppressor Protein p531201829540.070 Why?
Signal Transduction32020236450.070 Why?
B-Lymphocytes1202047930.070 Why?
Lymphoma1201618980.070 Why?
Practice Guidelines as Topic1202474540.070 Why?
Neutropenia220118920.060 Why?
Peptides1201843540.060 Why?
Antineoplastic Agents32018136760.060 Why?
Proto-Oncogene Proteins1201845280.060 Why?
Ambulatory Care1201627830.060 Why?
Nuclear Proteins1201858040.050 Why?
Gene Expression Regulation, Neoplastic1201886470.050 Why?
Protein Kinase Inhibitors1201857030.050 Why?
Humans1520247681660.050 Why?
Blood Cell Count120214060.040 Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 6120201210.040 Why?
Proto-Oncogene Proteins c-bcl-6120201900.040 Why?
STAT5 Transcription Factor120202680.040 Why?
Immunotherapy1201547550.040 Why?
Mice72022820290.040 Why?
Imidazolines12018180.040 Why?
Extracellular Signal-Regulated MAP Kinases120206150.040 Why?
Depsipeptides12018960.040 Why?
Neoplasm Recurrence, Local1201594190.030 Why?
Genes, myc120183910.030 Why?
Ikaros Transcription Factor120182330.030 Why?
Emergency Service, Hospital1201679510.030 Why?
Rabbits1202247720.030 Why?
Leukemia, Experimental120162250.030 Why?
Databases as Topic120174720.030 Why?
Chromosome Aberrations1202117780.030 Why?
Janus Kinase 2120185610.030 Why?
Proto-Oncogene Proteins c-myc120209980.030 Why?
Drug Therapy120185040.030 Why?
Antibodies1202224210.030 Why?
Isoquinolines120163540.030 Why?
Enzyme Activation1202035900.030 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma120162300.030 Why?
Equipment Failure Analysis120168450.030 Why?
Animals720221692460.030 Why?
Genes, p53120167140.030 Why?
Cell Differentiation12011116690.030 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive120186860.030 Why?
Drug Evaluation, Preclinical1201813380.030 Why?
Vincristine1201510400.030 Why?
Cell Line, Tumor22020171400.030 Why?
Remission Induction1201824100.020 Why?
Disease Models, Animal32018183490.020 Why?
Neoplasm Transplantation1201620140.020 Why?
Adenine120189950.020 Why?
Drug Resistance, Neoplasm2201853410.020 Why?
Mice, Inbred NOD1201618370.020 Why?
Random Allocation1201623960.020 Why?
Apoptosis1200795230.020 Why?
Patients120179080.020 Why?
Prednisone1201515670.020 Why?
Cyclophosphamide1201522270.020 Why?
Piperidines1201816670.020 Why?
Mutant Proteins120114880.020 Why?
Doxorubicin1201522340.020 Why?
Equipment Design1201635220.020 Why?
Mutation22015302380.020 Why?
Pyrazoles1201820280.020 Why?
Protein Denaturation120072420.020 Why?
Cell Lineage1201625750.020 Why?
Myelopoiesis120071350.020 Why?
Cell Cycle Proteins1201834450.020 Why?
Proteome1201618900.020 Why?
Protein Binding1201893430.020 Why?
Membrane Proteins1202278760.020 Why?
Pyrimidines1201830480.020 Why?
Treatment Outcome32018653710.020 Why?
Piperazines1201625540.020 Why?
Gene Expression1201875980.020 Why?
Disease-Free Survival1201568470.010 Why?
Molecular Targeted Therapy1201628300.010 Why?
Dose-Response Relationship, Drug12016107600.010 Why?
Medical Oncology1201623460.010 Why?
Neoplasm Proteins1201636030.010 Why?
Internet1201631100.010 Why?
Protein Folding120078710.010 Why?
Critical Care1201627150.010 Why?
Pilot Projects1201687410.010 Why?
Mice, Knockout12018144880.010 Why?
Length of Stay1201664980.010 Why?
Cells, Cultured12016190150.010 Why?
Cell Proliferation12016104740.010 Why?
Female520203971920.010 Why?
Research Design1201662110.010 Why?
Gene Expression Profiling1201695380.010 Why?
Randomized Controlled Trials as Topic12016103990.010 Why?
Mice, Transgenic1201195610.010 Why?
Phenotype12016167260.010 Why?
Male420163647190.010 Why?
Hospitalization12016108400.010 Why?
Prognosis12015300100.010 Why?
Aged220161715040.010 Why?
Mice, Inbred C57BL12011223790.010 Why?
Middle Aged220162234920.010 Why?
Adult220162236460.010 Why?
Aged, 80 and over12016596290.010 Why?
Young Adult12016600660.010 Why?
Pregnancy12011302560.000 Why?
Risk Factors12015749440.000 Why?
Adolescent12016891690.000 Why?
Retrospective Studies12015817620.000 Why?
Murakami's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (142)
Explore
_
Co-Authors (64)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.